|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of revenues | |||||
| Gross profit (loss) | |||||
| Research and development expenses | |||||
| General and administrative expenses | |||||
| Operating loss | |||||
| Financial income, net | |||||
| Financial (expenses) income: | |||||
| Revaluation of derivatives, warrants liabilities and others | |||||
| Other financing income (expenses), net | |||||
| Net loss | |||||
| Basic loss per ordinary share | |||||
| Diluted loss per ordinary share | |||||
| Weighted average number of ordinary shares outstanding used in computing basic loss per ordinary share | |||||
| Weighted average number of ordinary shares outstanding used in computing diluted loss per ordinary share | |||||
Loading...